Epiontis

Epiontis ID, a service under Precision for Medicine, specializes in immune monitoring and biomarker assay solutions. Operating within the life sciences sector, Epiontis ID supports the development of innovative therapeutics by allowing researchers to profile and uncover specific changes in the immune system. This is achieved through the measurement of cell epigenetic markers in DNA using quantitative PCR (qPCR). The service is designed to provide robust and consistent clinical immune monitoring, offering high reproducibility and comparability of data both within and across studies. Epiontis ID's technology enables accurate counting of cell types, providing scientists with flexibility in clinical study design due to the stability of DNA and the automated nature of the process. The service caters to researchers and scientists involved in clinical trials and therapeutic development, offering over 30 prevalidated cell types for customized panels. Epiontis ID generates revenue through service fees for its immune monitoring solutions, primarily targeting pharmaceutical companies, biotech firms, and research institutions.

Keywords: immune monitoring, biomarker assay, qPCR, epigenetic markers, clinical trials, therapeutic development, life sciences, cell profiling, DNA analysis, Precision for Medicine.